Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

1.1 List of Tables

Table 1: Number of Products under Development for Ureter Cancer 10

Table 2: Number of Products under Development by Companies, Ureter Cancer 11

Table 3: Number of Products under Development by Universities/Institutes, Ureter Cancer 12

Table 4: Products under Development by Companies, Ureter Cancer 13

Table 5: Products under Development by Universities/Institutes, Ureter Cancer 13

Table 6: Number of Products under Development for Bladder Cancer 14

Table 7: Number of Products under Development by Companies, Bladder Cancer 16

Table 8: Number of Products under Development by Universities/Institutes, Bladder Cancer 21

Table 9: Products under Development by Companies, Bladder Cancer 22

Table 10: Products under Development by Universities/Institutes, Bladder Cancer 32

Table 11: Number of Products by Stage and Target, Ureter Cancer 35

Table 12: Number of Products by Stage and Mechanism of Action, Ureter Cancer 37

Table 13: Number of Products by Stage and Route of Administration, Ureter Cancer 39

Table 14: Number of Products by Stage and Molecule Type, Ureter Cancer 40

Table 15: Number of Products by Stage and Target, Bladder Cancer 42

Table 16: Number of Products by Stage and Mechanism of Action, Bladder Cancer 48

Table 17: Number of Products by Stage and Route of Administration, Bladder Cancer 55

Table 18: Number of Products by Stage and Molecule Type, Bladder Cancer 57

Table 19: Ureter Cancer – Pipeline by Altor BioScience Corp 58

Table 20: Ureter Cancer – Pipeline by Eisai Co Ltd 58

Table 21: Ureter Cancer – Pipeline by Exelixis Inc 59

Table 22: Ureter Cancer – Pipeline by GlaxoSmithKline Plc 59

Table 23: Ureter Cancer – Pipeline by MedImmune LLC 60

Table 24: Ureter Cancer – Pipeline by Merck & Co Inc 60

Table 25: Bladder Cancer – Pipeline by 4SC AG 61

Table 26: Bladder Cancer – Pipeline by Abivax SA 61

Table 27: Bladder Cancer – Pipeline by Adaptimmune Therapeutics Plc 62

Table 28: Bladder Cancer – Pipeline by ADC Therapeutics Sarl 62

Table 29: Bladder Cancer – Pipeline by Altor BioScience Corp 63

Table 30: Bladder Cancer – Pipeline by AndroScience Corp 63

Table 31: Bladder Cancer – Pipeline by ANP Technologies Inc 64

Table 32: Bladder Cancer – Pipeline by APIM Therapeutics AS 64

Table 33: Bladder Cancer – Pipeline by Archivel Farma SL 65

Table 34: Bladder Cancer – Pipeline by Argos Therapeutics Inc 65

Table 35: Bladder Cancer – Pipeline by Arno Therapeutics Inc 66

Table 36: Bladder Cancer – Pipeline by Array BioPharma Inc 66

Table 37: Bladder Cancer – Pipeline by Asana BioSciences LLC 67

Table 38: Bladder Cancer – Pipeline by Asieris Pharmaceuticals Co Ltd 67

Table 39: Bladder Cancer – Pipeline by Astellas Pharma Inc 68

Table 40: Bladder Cancer – Pipeline by Astex Pharmaceuticals Inc 68

Table 41: Bladder Cancer – Pipeline by AstraZeneca Plc 69

Table 42: Bladder Cancer – Pipeline by AVEO Pharmaceuticals Inc 69

Table 43: Bladder Cancer – Pipeline by Bavarian Nordic A/S 70

Table 44: Bladder Cancer – Pipeline by Bayer AG 70

Table 45: Bladder Cancer – Pipeline by Biocad 71

Table 46: Bladder Cancer – Pipeline by BioCancell Ltd 71

Table 47: Bladder Cancer – Pipeline by Biohaven Pharmaceutical Holding Company Ltd 72

Table 48: Bladder Cancer – Pipeline by Biomics Biotechnologies Co Ltd 72

Table 49: Bladder Cancer – Pipeline by Biotest AG 73

Table 50: Bladder Cancer – Pipeline by Boehringer Ingelheim GmbH 73

Table 51: Bladder Cancer – Pipeline by Bristol-Myers Squibb Co 74

Table 52: Bladder Cancer – Pipeline by Celgene Corp 74

Table 53: Bladder Cancer – Pipeline by Celldex Therapeutics Inc 75

Table 54: Bladder Cancer – Pipeline by Celprogen Inc 75

Table 55: Bladder Cancer – Pipeline by Celsion Corp 76

Table 56: Bladder Cancer – Pipeline by Celyad SA 76

Table 57: Bladder Cancer – Pipeline by Cleveland BioLabs Inc 77

Table 58: Bladder Cancer – Pipeline by Cold Genesys Inc 77

Table 59: Bladder Cancer – Pipeline by Corvus Pharmaceuticals Inc 78

Table 60: Bladder Cancer – Pipeline by CytomX Therapeutics Inc 78

Table 61: Bladder Cancer – Pipeline by Cytori Therapeutics Inc 79

Table 62: Bladder Cancer – Pipeline by Daiichi Sankyo Co Ltd 79

Table 63: Bladder Cancer – Pipeline by Eisai Co Ltd 80

Table 64: Bladder Cancer – Pipeline by Eleven Biotherapeutics Inc 80

Table 65: Bladder Cancer – Pipeline by Eli Lilly and Co 81

Table 66: Bladder Cancer – Pipeline by Elsalys Biotech SAS 82

Table 67: Bladder Cancer – Pipeline by EpiThany Inc 82

Table 68: Bladder Cancer – Pipeline by Esperance Pharmaceuticals Inc 83

Table 69: Bladder Cancer – Pipeline by Exelixis Inc 83

Table 70: Bladder Cancer – Pipeline by Exicure Inc 84

Table 71: Bladder Cancer – Pipeline by F. Hoffmann-La Roche Ltd 84

Table 72: Bladder Cancer – Pipeline by Five Prime Therapeutics Inc 85

Table 73: Bladder Cancer – Pipeline by Gene Signal International SA 85

Table 74: Bladder Cancer – Pipeline by Genentech Inc 86